Melbourne, Australia, 8 October 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “the Company”), a medical technology company developing and commercialising innovative IVD tests, is expanding its operations and moving to a new location adjacent to CSIRO and the Monash Technology Precinct.
Sienna advances its plans to become a hub for IVD test development and commercialisation
New premises are located near CSIRO and the Monash Technology Precinct
New manufacturing facilities for SIEN-NETTM product line to be built
For further information please download the attached PDF:
Download this document